ID   Lec8/hPDPN
AC   CVCL_D2U2
RX   Patent=US10227407;
RX   PubMed=25080943;
RX   PubMed=26937552;
RX   PubMed=27328060;
CC   Sequence variation: Mutation; UniProtKB; Q99PG7; Slc35a2; Simple; p.Gly92Ter (c.275_374del); Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 29602; PDPN.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3443 ! Lec8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 30-01-24; Version: 1
//
RX   Patent=US10227407;
RA   Kato Y., Kaneko M.K.;
RT   "Anti-podoplanin antibody.";
RL   Patent number US10227407, 12-Mar-2019.
//
RX   PubMed=25080943; DOI=10.1038/srep05924;
RA   Kato Y., Kaneko M.K.;
RT   "A cancer-specific monoclonal antibody recognizes the aberrantly
RT   glycosylated podoplanin.";
RL   Sci. Rep. 4:5924-5924(2014).
//
RX   PubMed=26937552; DOI=10.1089/mab.2015.0077;
RA   Kato Y., Ogasawara S., Oki H., Honma R., Takagi M., Fujii Y.,
RA   Nakamura T., Saidoh N., Kanno H., Umetsu M., Kamata S., Kubo H.,
RA   Yamada M., Sawa Y., Morita K.-i., Harada H., Suzuki H., Kaneko M.K.;
RT   "Novel monoclonal antibody LpMab-17 developed by CasMab technology
RT   distinguishes human podoplanin from monkey podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:109-116(2016).
//
RX   PubMed=27328060; DOI=10.1089/mab.2016.0006;
RA   Ogasawara S., Kaneko M.K., Honma R., Oki H., Fujii Y., Takagi M.,
RA   Suzuki H., Kato Y.;
RT   "Establishment of mouse monoclonal antibody LpMab-13 against human
RT   podoplanin.";
RL   Monoclon. Antib. Immunodiagn. Immunother. 35:155-162(2016).
//